Pneuma - IndieBio - #1 in Early Stage Biotech
Watch: SF Demo Day / Jan 19 and NY Demo Day / Feb 7. IndieBio is a program of SOSV, a global venture capital firm providing multi-stage investment to support big ideas. NY and SF next cohorts will start late spring 2023. IndieBio companies include any and all sectors where biology can be used to engineer novel solutions. Become a part of the greater IndieBio community through our virtual and in-person network opportunities.
This company is:
Verified
The Most Incredible Technology You've Never Seen - IndieBio - #1 in Early Stage Biotech
Guest post By Bryan Johnson, founder of Kernel, OS Fund, and Braintree Saving the world (or some subset of people in it) is in vogue among the world’s wealthiest. Jeff Bezos has a rocket company, Blue Origin. Bezos believes our future is extraterrestrial, and his rocket company exists because he thinks the price for getting anything […]
Verified
Prellis Biologics collaborates with Sanofi to expand production of organoids - IndieBio - #1 in Early Stage Biotech
3D Printing Media Network reported “Prellis Biologics to provide human lymph node organoids for research” and announced the startup will leverage its external human immune system (EXIS) in a collaboration and licensing agreement with the healthcare giant Sanofi. Prellis Biologics (SOSV IBSF05 2017) engineers fully-human lymph node organoids (LNOs) and recreates immune responses in vitro […]
Verified
An Interview With Arshia Firouzi of Ravata Solutions - IndieBio - #1 in Early Stage Biotech
Electronic Embryo Alteration. Photo: Arshia Firouzi (left) and Gurkern Sufi. There are numerous reasons why new therapeutics take so long to become accessible to people suffering from life-threatening diseases. Many lab animals which are used in the testing of new treatments, most notably mice, often need to be genetically modified in order for them to best represent […]
View all products
Keywords
Industries
IndieBio Call for Applications - IndieBio - #1 in Early Stage Biotech
SOSV Announces Launch of IndieBio New York — World’s leading life sciences accelerator expands to New York City —— Call for Applications Open Now — (NEW YORK, January 7th, 10:30am EST) — SOSV, the world’s most active investor in both life sciences and hardware, announced that the inaugural cohort of IndieBio New York will start […]
Where is IndieBio located?
The company IndieBio is located in San Francisco, California, United States. It's worth noting that the company may has more corporate locations
How many employees does IndieBio approximately have?
As of the latest available information IndieBio has around 1-10 employees worldwide.
When was IndieBio founded?
IndieBio was founded in 2014
In which industries does IndieBio mainly work?
The company IndieBio has it's main focus in the industries of Biotechnology, Science and Engineering, Financial Services, Lending and Investments
SOSV
United States
101-250 Employees
1994
Inso Biosciences
United States
1-10 Employees
2018
SynBioBeta
United States
1-10 Employees
2012
Design Technologies
United States
1-10 Employees
Mission BioCapital
United States
11-50 Employees
2009
S Phase Bio Fund
United States
11-50 Employees
San Diego Biotechnology
United States
11-50 Employees
2008
SV Health Investors
United States
101-250 Employees
1993
Topics which have been searched by others and may be interesting for you:
